Skip to main content

1Provenance card

the boundary, as counts

Sources

3831 with DOI

5 strong · 30 moderate · 3 weak

Compilations

12026-05-14T05:43:59.266Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

23last ruled 2026-06-04

0 awaiting a ruling

Issued documents

62026-10-19T20:30:45.598Z

notice · info card · emergency

Searches

262 with no results

queries and counts on the build

Claims checked

16222 supported

22 supported · 140 not

Correspondence

0received

consent field ships in Phase 4

Edges

426

derivations recorded for this entity

Complete over 38 sources, 1 compilation, and 23 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/banisteriopsis-caapi/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-19issueIssued notice
  4. 2026-09-07srcKinetic profile of N,N-dimethyltryptamine and beta-carbolines in saliva and serum after oral administration of ayahuasca
  5. 2026-09-07srcGas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage
  6. 2026-09-07srcHarmaline attenuates pain and inflammation: role of IL-1beta, oxidative stress, nitric oxide and cyclo-oxygenase
  7. 2026-09-07srcLong-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users
  8. 2026-09-07srcExamining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: a factorial dose-escalation study
  9. 2026-09-07srcValidation of an analytical method for the determination of the main ayahuasca active compounds
  10. 2026-09-07srcComposition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease
  11. 2026-09-07srcClassical hallucinogens and neuroimaging: A systematic review of human studies
  12. 2026-09-07srcIntoxication Associated with Ayahuasca Consumption, Characterization, and Comparative Analysis of the Beverage's Components: A Case Report
  13. 2026-09-07srcA dispersive liquid-liquid microextraction method for the determination of ayahuasca alkaloids in human hair
  14. 2026-09-07srcAyahuasca and the traveller: A scoping review of risks and possible benefits
  15. 2026-09-07srcRapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
  16. 2026-09-07srcThe alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro
  17. 2026-09-07srcEffects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination
  18. 2026-09-07srcEffect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users
  19. 2026-09-07srcAssessing the Psychedelic After-Glow in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities
  20. 2026-09-07srcHarmala Alkaloids Identify Ayahuasca Intoxication in a Urine Drug Screen
  21. 2026-09-07srcDevelopment of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans
  22. 2026-09-07srcAutonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine
  23. 2026-09-07srcHarmine augments electrically evoked dopamine efflux in the nucleus accumbens shell
  24. 2026-09-07srcPersonality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study
  25. 2026-09-07srcThe psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network
  26. 2026-09-07srcRisk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
  27. 2026-09-07srcAyahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
  28. 2026-09-07srcThe Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization
  29. 2026-09-07srcMolecular Pathways of the Therapeutic Effects of Ayahuasca
  30. 2026-09-07srcAyahuasca as a Decoction Applied to Human: Analytical Methods, Pharmacology and Potential Toxic Effects
  31. 2026-09-07srcComponents of Banisteriopsis caapi, a Plant Used in the Preparation of the Psychoactive Ayahuasca, Induce Anti-Inflammatory Effects in Microglial Cells
  32. 2026-09-07srcDated Phylogeny of Banisteriopsis (Malpighiaceae) Suggests an Ancient Colonization of the Cerrado and No Evidence of Human Manipulation in the Origin of B. caapi
  33. 2026-09-07srcBiodiversity of β-Carboline Profile of Banisteriopsis caapi and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential
  34. 2026-09-07srcA complete generic phylogeny of Malpighiaceae inferred from nucleotide sequence data and morphology
  35. 2026-09-07srcDetermination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca
  36. 2026-09-07srcHuman pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
  37. 2026-09-07srcBringing ayahuasca to the clinical research laboratory
  38. 2026-09-07srcHypothermic effect of harmala alkaloid in rats: involvement of serotonergic mechanism
  39. 2026-09-07srcQuantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca
  40. 2026-09-07srcAyahuasca Legal Status by Country
  41. 2026-09-07srcBanisteriopsis caapi (Spruce ex Griseb.) C.V.Morton
  42. 2026-09-04issueIssued emergency
  43. 2026-09-04issueIssued info_card
  44. 2026-09-04issueIssued notice
  45. 2026-06-04proposal18 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  46. 2026-06-04publicationPublication — backfill
  47. 2026-05-14revisionRevision 2
  48. 2026-05-14absenceSearched PubMed for "Banisteriopsis caapi ethnobotany ayahuasca history" — no results
  49. 2026-05-14absenceSearched PubMed for "ayahuasca adverse effects safety toxicity case report" — no results
  50. 2026-05-14genGeneration — pipeline-v5 · with 4 morepipeline-v5
  51. 2026-05-14rungeneration run
  52. 2026-03-17importImported from Curiosity v1
  53. 2026-03-17publicationPublication — backfill
  54. 2026-03-17revisionRevision 1

The same entries, as forms: six forms.